Object. The authors studied the reliability of a new method for noninvasive assessment of cerebral perfusion pressure (CPP) in head-injured patients in which mean arterial blood pressure (ABP) and transcranial Doppler middle cerebral artery mean and diastolic flow velocities are measured.
LTHOUGH many factors may affect outcome in the patient with head injury, an increase in intracranial pressure (ICP) and a reduction in arterial blood pressure (ABP) are both independently predictive of poor outcome. 11 Both systemic hypotension and intracranial hypertension lead to a reduction in cerebral perfusion pressure (CPP) and a potential decrease in cerebral blood flow (CBF), causing secondary ischemic insults. 3, 8, 9, 12, 19 Therefore, the goal of intensive care of head-injured patients is to optimize CPP, a targeted therapy that shows promise as a method to improve outcome after head trauma. 19 Direct measurement of CPP is complex; the difference between ABP and ICP, although considered the "gold standard," may prove inaccurate in clinical practice. Errors in the measurement of ICP may result from long-term or temperature-induced drifts of the transducer used 4 or, in case of using contemporary microtransducers, from uneven distribution of intraparenchymal pressure within the brain. 18 The less invasive epidural probes have been shown to produce case-and time-dependent errors up to 20 mm Hg.
14 There are also potential errors in the measurements of ABP. Arterial pressure at the level of the brain is often underestimated because all invasive pressure monitoring devices measure readings from peripheral vessels prone to vasospasm and atherosclerosis. Therefore, "real CPP" should not be considered a number but rather a condition for cerebral blood to flow.
Varying CPP produces specific changes in CBF velocity (FV) measured by transcranial Doppler (TCD) ultrasonography 2, 6 with stable systolic and falling diastolic values. These changes may be observed in the so-called pulsatility index (defined either as Gosling pulsatility index [GPI], the peak-to-peak amplitude of FV pulsations divided by time-averaged FV, or as "spectral" pulsatility index [SPI] , the first harmonic component of FV pulsations divided by mean FV), which has been reported to be inversely proportional to CPP. 2, 6 In 1986 Aaslid, et al., 1 proposed a formula for estimating CPP by relating the first harmonic component of the ABP pulse waveform to SPI. Although sufficiently sensitive to detect changes of CPP over time, this method proved to have a limited absolute accuracy (the 95% prediction error is as wide as Ϯ 27 mm Hg 5 ). The present study aimed to address the following ques-tions: 1) Is it possible to estimate CPP more accurately? 2) Is it possible to monitor changes in CPP continuously in a noninvasive fashion? 3) When using TCD ultrasonography, what are the factors limiting the accuracy of noninvasive estimation of CPP?
Clinical Material and Methods

Patient Population
Data were collected from 96 patients suffering from head injury (31 females and 65 males). The patients, whose mean age was 35 years (range 6-75 years) were admitted to the neurointensive care unit at Addenbrooke's Hospital, Cambridge, United Kingdom with a mean Glasgow Coma Scale score of 6 (range 3-12). All patients were sedated with infusions of propofol, fentanyl, and/or midazolam. Muscle relaxation was achieved by using an infusion of atracurium besylate. The patients' lungs were mechanically ventilated with an air-oxygen mixture to maintain adequate oxygenation (PaO 2 Ͼ 12 kPa) and mild hypocapnia (PaCO 2 35 Ϯ 5 mm Hg). Intravenous fluids and inotropic support (dopamine, noradrenaline, or adrenaline) were provided as appropriate to achieve and maintain a CPP above 60 mm Hg. Episodes of intracranial hypertension (mean ICP Ͼ 25 mm Hg for Ն 15 minutes) were treated according to an accepted protocol that included additional blood pressure increases, hyperventilation, and infusions of mannitol (200 ml of 20% mannitol spread over Ն 20 minutes). Patients in whom bone flaps were removed were excluded. Outcome was assessed 6 months after injury.
Monitoring of Patients
In addition to routine systemic hemodynamic monitoring (ABP, central and pulmonary artery pressures, electrocardiography, and pulse oximetry), ICP and CBFVs were also monitored. The patients' ICP was measured by using a fiberoptic transducer that was inserted intraparenchymally into the right frontal region. Blood pressure was measured directly in the radial artery or the dorsal artery of the foot using a bedside monitor. Cerebral blood FVs were measured daily by transtemporal insonation of the middle cerebral artery (MCA) (20-120 minutes) from the day of admission until discharge or Day 8 after head injury, which was accomplished by using a 2-MHz probe that was supported by a simple rubber strap. The signal of low noise and stable waveform was detected from a depth varying from 4.5 to 5.7 cm, avoiding any section of artery in which the mean FV was above 120 cm/second, indicating the possibility of spasm. This limitation was imposed by the ultrasonograph we used, because it was unable to measure velocity above 200 cm/second.
Signals were monitored during stable ventilatory and nursing periods. Data were excluded during physiotherapy, tracheal suction, and any other nursing maneuvers. The monitoring periods were not related to any particular physiological phenomena and were distributed randomly throughout the day.
Data Capture and Calculations
Analog outputs from the pressure monitors and the TCD unit (maximal frequency envelope) were connected to the analog-to-digital converter that was fitted into a laptop computer. Data were sampled (sampling frequency 50 Hz), digitized (12 bits), and stored on the computer hard disk by using software designed for waveform recording. 21 Digital time series were then processed using software developed in house (by M.C.).
Time-averaged (mean) values of ICP, ABP, CPP (ICPm, ABPm, CPPm, respectively [CPPm = ABPm Ϫ ICPm]) were calculated using time integration of waveforms for 5-second intervals. Time-averaged mean, systolic, and diastolic values of FV (FVm, FVs, and FVd, respectively) were calculated after careful spectral filtration to reduce an influence of artifacts and noise and averaged within the same 5-second periods. Digital Fourier analysis 7 was used to evaluate the first harmonic components of arterial pressure (A1) and CBFV (F1) pulse waveforms. Two estimates of CPP were then evaluated: 1) estimate of CPP described by Aaslid, et al., 1 A1*FVm/F1; and 2) our own formula, ABPm*FVd/FVm.
The first estimate is based on the SPI (F1/FVm); however, it can also be interpreted as the difference between ABP and critical closing pressure (calculated as ABPm Ϫ A1/F1*FVm). The second estimate cannot be related directly to critical closing pressure. A potential disadvantage of both methods is that they are unable to compensate for changes in vascular resistance as long as they do not exert a secondary impact on ABP or ICP. For example, during hyperventilation, vascular resistance decreases and the pulsatility index decreases; therefore, the estimate of Aaslid, et al., increases. Conversely, FVd/FVm decreases with hyperventilation (although generally FVd/ FVm is less mobile than F1/FVm), decreasing our estimate of CPP.
Statistical Analysis
Estimates of CPP using both formulas measured CPP (CPPm), ICP (ICPm), ABP (ABPm), and FV (FVm); GPI and SPI were averaged over all examinations made in the same patient. These values were then correlated with CPPm. The Mann-Whitney test was used to compare differences in monitored and predicted parameters in patients with different outcomes.
The modified maximum likelihood estimation method 15 Noninvasive CPP assessment was adopted to minimize error for the CPP estimation. In this method, unknown parameters (constant and multiplicative terms) are estimated to maximize the rate of measurements with an error measuring less than or equal to 15 mm Hg and 10 mm Hg, respectively.
Sources of Supplies and Equipment
The fiberoptic transducer used in the experiments was the Camino Direct Pressure Monitor available from Camino Laboratories (San Diego, CA). Blood pressure was measured using the System 800 bedside monitor from S & W Vickers Ltd., Sidcup, United Kingdom). Cerebral blood FVs were measured using the PCDop 842 Doppler Ultrasound Unit, purchased from SciMed, Bristol, United Kingdom). For data capture and calculations, we used the DT 2814 analog-to-digital converter, obtained from Data Translation, Marlboro, MA fitted into a 386SX laptop personal computer. Data were sampled, digitized, and stored using WREC software from W. Zabolotny, Warsaw University of Technology, Poland.
Results
Transcranial Doppler Pulse Waveform and CPP
The FVd/FVm ratio and the SPI (F1/FVm) are crucial for quality CPP estimation. The average relationship between these variables and real CPP found in 96 patients is shown in Fig. 1 . Although there was an inverse relationship between the SPI and CPP (r = 0.47; p Ͻ 0.001; 96 patients), the FVd/FVm ratio showed better correlation (r = 0.65; p Ͻ 0.0001; 96 patients, exponential model). This is highlighted in Fig. 1 by the smaller scattering of the measurement points around the modeling curve.
Estimation of CPP
The results of regression analysis of CPP compared with estimates of CPP are shown in Fig. 2 . A linear predictive model was found to be the most suitable in both cases: 7.72 + 1.14*ABPm*FVd/FVm; r = 0.728; F = 89; p = 0.000001; 96 patients and 34 + 0.529*A1*FVm/F1; r = 0.501; F = 26; p = 0.00001; 96 patients.
Our estimator of CPP (eCPP) was associated with better 95% confidence limits for predictors than the estimate of CPP proposed by Aaslid, et al., 1 (aCPP) (Ϯ 21 mm Hg and Ϯ 29 mm Hg, respectively). Both estimators demonstrated a high positive predictive power to detect decreases in real CPP below 60 mm Hg (94% and 84%, respectively). Unfortunately, the negative predictive power in both methods was poor (38% and 36%, respectively).
Further analysis indicated that the maximum likelihood estimators can be evaluated as: eCPP = ABPm*FVd/ FVm + 14 and aCPP = A1*FVm/F1 + 15.
The eCPP was less than 10 mm Hg different from real CPP in 71% of the measurements, whereas only 52% of the aCPP was within 10 mm Hg of real CPP. This difference was significant at p Ͻ 0.0001 (Fig. 3) .
Accuracy of ICP Estimation
Using the maximum likelihood method, estimated ICP (eICP) may be predicted as: eICP = ABPm*(1 Ϫ FVd/ FVm) Ϫ 14.
The error in estimating ICP by less than 10 mm Hg was achieved in 68% of the measurements. However, it was possible to reduce the error in ICP estimation to less than 5 mm Hg in only 39% of the measurements.
A summary of median values, both measured and estimated in patients with different outcomes, is presented in Table 1 . There was no difference between CPPs in patients with favorable and unfavorable outcome, probably signifying the success of the CPP-oriented therapy we use in our center.
Monitoring of Changes in Real CPP Over Time
Estimated CPP was highly specific for detecting changes in measured CPP as a result of either increases in ICP (plateau waves) or systemic hypotension.
In six patients with ICP plateau waves, eCPP compared with measured CPP had an average goodness-of-fit coefficient r 2 of 0.82. An example is provided in Fig. 4 upper.
Furthermore, the eCPP was very sensitive for detecting decreases in ABP below 70 mm Hg (in 10 patients) with an average goodness-of-fit coefficient r 2 of 0.92 (Fig. 4  center) . The B waves (observed in seven patients) in ICP and ABP, which affect real CPP, can also be detected by the eCPP (Fig. 4 lower) .
Five or more daily examinations were performed in 41 patients. Day-by-day variations in measured CPP that was 15 mm Hg or greater (25 patients) were reflected by variations in eCPP with a goodness-of-fit coefficient r 2 of 0.71 (see example in Fig. 5 ).
Confounding Factors
Changes in cerebrovascular resistance, such as that produced by variations in PaCO 2 , may disturb CPP estimation. Although an increase in arterial CO 2 tension (from mild hypocapnia to normocapnia) decreased the measured CPP (increasing ICP on average by 5 mm Hg in four patients), it often resulted in a slight increase in eCPP (mainly because of an increase in the FVd/FVm factor due to vasodilation).
Similarly, in patients with artery stenosis or proximal spasm (three patients), CPP was overestimated ipsilateral to the stenosis (average side-to-side difference 11 mm Hg). Possible proximal vasospasm may also be one confounding factor. However, an error in CPP estimation was not related to the evidence of subarachnoid blood visible on computerized tomography scanning or to mean FV increased above 80 cm/second. On the other hand, one should bear in mind that our equipment was not able to pick up blood velocities within the range normally observed in severe vasospasm (that is, FVs Ͼ 200 cm/ second).
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Noninvasive CPP assessment Discussion A noninvasive CPP estimation will be advantageous to those caring for patients with head injuries, especially in centers where neurosurgical expertise is not immediately available. Patients in whom no surgical intervention is warranted at the time of admission may benefit, but some measure of CPP is required without the risks and costs of invasive ICP monitoring. Furthermore, noninvasive estimation of CPP will provide a measure of CPP in patients at risk from cerebral ischemia during nonneurosurgical procedures, such as liver transplantation, in whom coagulation abnormalities prevent insertion of ICP monitoring devices.
Many attempts have been made to find an "estimator" for CPP;
1,10 however, there is no currently available method accurate enough to be clinically useful. In this study, we attempted to highlight the benefits of our CPP estimation method, which although limited in its ability to predict CPP as a number is able to provide a reasonable detection of changes in real CPP over time. Both the rate of achieving an absolute error below 15 mm Hg and a positive predictive power to detect CPP below 60 mm Hg proved to be high. The method may be used as a noninvasive alarm in continuous monitoring of patients after mild and moderate head injury. Both the value of estimated CPP below 60 mm Hg and a decrease in CPP seen over time should stand as a warning of cerebral hypoperfusion, whereas a stable value of predicted CPP above 60 mm Hg does not necessarily indicate good cerebral hemodynamic reserve.
Contrary to the method proposed by Aaslid, et al., 1 our formula has no elegant physiological or hemodynamic interpretation; it is purely based on the authors' 6 years of clinical experience. We may summarize that for the range of higher CPPs (Ͼ 70 mm Hg) changes in ABP mainly contribute to variations seen in CPP, whereas for the range of low CPPs the high ICP (best detected by decreasing the FVd/FVm factor [ Fig. 1]) is a stronger contributer to variations in cerebral perfusion. Therefore, the combination (multiplication) of the mean ABP and nonlinear CPPdependent FVd/FVm factor produces our formula. The method has a lower saturation level of 14 mm Hg when FVd disappears. In clinical practice, this phenomenon in itself should warn us of a deeply inadequate level of cerebral perfusion and trigger an immediate attempt to recover a normal pattern of CBF in basal arteries.
Noninvasive Monitoring of the Time-Dependent Changes in CPP
The most important advantage of using our noninvasive CPP estimator is the ability to detect fluctuations in real CPP over time. We were reliably able to detect changes in CPP that were induced by episodes of intracranial hypertension, arterial hypotension, and arterial hypertension. However, we must emphasize that moderate nonvasogenic fluctuations in ICP (10 mm Hg) are not reliably detected because these changes may not induce sufficient hemodynamic stress to change the FV waveform. On the other hand, vasogenic waves in ICP (5-10 mm Hg) are readily detected by using our estimator.
Accuracy of CPP Estimation
By using our formula, we were able to estimate CPP more accurately than by using the previously proposed method. 1 Estimation error was less than 10 mm Hg and 15 mm Hg, respectively, in 71% and 84% of the measurements (421 patients) compared with 52% and 64% achieved using an alternative formula 13 (rates significantly different at p Ͻ 0.001). Average absolute error (Table  1 ) was approximately 6.5 mm Hg, which may be considered by a majority of neurointensive care physicians as acceptably low. Apart from knowing CPP as a number, the most important clinical application of the method is to monitor relative changes in CPP over time. Ultrasound probes, once mounted, may be easily kept in position over a longer period. A decrease in the estimated CPP measured over time should trigger either appropriate therapy or introduction of direct ICP monitoring.
Another interesting possibility is to assess the left-right side difference between bilaterally estimated CPP. Such a project is in progress and we hope to present these results soon.
Assessment of ICP
Because of their low accuracy, many methods available for the noninvasive measurement of ICP have not been adopted in clinical practice. Although the tympanic membrane displacement 17 and TCD pulsatility index 16 are useful for the assessment of shunt patency in patients with hydrocephalus, it is not possible to obtain an accurate ICP measurement by using either method. The transfontanelle pressure method of ICP measurement is useful in newborns and infants; however, there have been doubts about whether it can measure ICP accurately. 13 The less invasive epidural catheters used for ICP measurement are prone to both case-and time-dependent errors. 10 Our method of ICP estimation is not radically better than previously described algorithms based on TCD waveform analysis. 1, 10 Theoretically, the noninvasive estimation of CPP suffers from the same degree of inaccuracy as the noninvasive assessment of ICP. However, because ICP is much lower than CPP, a 10-mm Hg error is unacceptable in estimating ICP, whereas this degree of error seems to be satisfactorily low for CPP estimation. Furthermore, in many situations (such as head injury with midline shift), the circulation of cerebrospinal fluid is disturbed to such an extent that real intraparenchymal pressure may be unevenly distributed within the brain. Therefore, "real ICP" observed with intraparenchymal transducers may be different from the one affecting dynamics of blood FV in the MCA, 20 and, hence, estimated using the TCD waveform.
Conclusions
We have reported a new method for noninvasive assessment of CPP. This CPP estimator can predict real CPP with an error margin of less than 10 mm Hg over 70% of the time. This is of potential benefit for continuous monitoring of changes in real CPP over time in situations in which direct measurement of CPP is not readily available.
